Position in BIIB
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$1,737,770
+$263,247 QoQ
Shares Held
8,043
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.39%
of 13F equity value
Holder Rank
#360
of 1,037 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cairn Investment Group, Inc. holds $15,565,541 across 7 Drug Manufacturers - General names. BIIB ranks #4 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
54,875 | $7,051,437 | |
| 2 | LLY |
ELI LILLY & Co
|
2,610 | $3,130,512 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
21,247 | $2,684,345 | |
| 4 | BIIB |
Biogen Inc.
This page
|
8,043 | $1,737,770 | |
| 5 | NVO |
Novo Nordisk A S
|
9,333 | $447,424 | |
| 6 | JNJ |
Johnson & Johnson
|
1,060 | $269,208 | |
| 7 | ABBV |
AbbVie Inc.
|
973 | $244,845 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,737,770 | 8,043 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $1,474,523 | 8,043 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,424,815 | 8,096 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,149,216 | 8,204 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,039,131 | 8,274 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,143,435 | 8,356 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,278,869 | 8,363 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $2,232,261 | 11,516 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $2,584,793 | 11,150 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $2,443,734 | 11,333 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $2,879,075 | 11,126 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,776,479 | 10,803 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $2,900,057 | 10,181 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $2,730,254 | 9,820 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $2,648,739 | 9,565 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $2,435,040 | 9,120 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $1,878,287 | 9,210 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $1,918,566 | 9,110 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,883,372 | 7,850 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,051,677 | 7,250 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,471,328 | 7,137 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,947,619 | 6,962 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,736,547 | 7,092 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,988,596 | 7,010 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $314,371 | 1,175 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $389,147 | 1,230 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||